CompanyGraph
Pw Medtech Group Ltd.
1358 · HKEX · China
Price data from its PWE listing on FSX, quoted in EUR
pwmedtech.comFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $249.86M, lower than 95% of all stocks globally
- PositionP/E ratio is 12.86×, lower than 95% of its Medical Instruments & Supplies peers (median 26.23×)
- Interpretations6 currently firing — 1 · 5
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
4.42%
Annual Rate
HKD 0.04Paid semi-annual
Payout Ratio
141.9%High
Payback Period
1.4 yr
Next Ex-Dividend
Nov 2, 2026
Screen for this company's dividend patterns
Find other companies where the same dividend readings fire.
High Dividend Payout With FCF And Equity Ratio
→dividend payout intensity
fcf positive 3y
ratio balance equity
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company return capital?
High Dividend Payout With FCF And Equity Ratio
It pays out most of its earnings, on three years of positive free cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.96BHKD249.86M · vs all stocks (USD)
Trailing P/E
12.86xvs Medical Instruments & Supplies peers
Revenue (TTM)
939.34MCNY119.74M · vs all stocks (USD)
Profit Margin
5.36%vs Medical Instruments & Supplies peers
Beta
0.7000xvs all stocks
52-Week Change
-42.40%vs all stocks
Forward Annual Dividend Yield
4.42%vs all stocks
Market Capitalization
1.96BHKD249.86M · vs all stocks (USD)
Enterprise Value
478.44MHKD60.99M · vs all stocks (USD)
Trailing P/E
12.86xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.60xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
0.2837xvs Medical Instruments & Supplies peers
Enterprise to Revenue
0.5090xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
1.82xvs Medical Instruments & Supplies peers
Profit Margin
5.36%vs Medical Instruments & Supplies peers
Operating Margin
10.86%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.03%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
1.80%vs Medical Instruments & Supplies peers
Revenue (TTM)
939.34MCNY119.74M · vs all stocks (USD)
Revenue per Share (TTM)
0.5360CNYUpdated Sep 20, 2026Quarterly Revenue Growth
-4.90%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
449.78MCNY57.33M · vs all stocks (USD)
EBITDA (TTM)
300.92MCNY38.36M · vs all stocks (USD)
Net Income (TTM)
50.37MCNY6.42M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-77.70%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
240.70MCNY30.68M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
94.37MCNY12.03M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0400HKDUpdated Sep 20, 2026Forward Annual Dividend Yield
4.42%vs all stocks
Trailing Annual Dividend Rate
0.0640HKDUpdated Sep 20, 2026Trailing Annual Dividend Yield
7.07%vs all stocks
Payout Ratio
141.93%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
903.26MCNYFY2025 · Dec 31, 2025Revenue
823.50MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
416.05MCNYFY2025 · Dec 31, 2025Gross Profit
407.46MCNYFY2025 · Dec 31, 2025Operating Income
102.05MCNY15.23M · vs all stocks (USD)
Pre-tax Income
164.99MCNYFY2025 · Dec 31, 2025Income Tax Expense
29.74MCNYFY2025 · Dec 31, 2025Net Income
135.25MCNYFY2025 · Dec 31, 2025EBIT
165.71MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
300.92MCNYFY2025 · Dec 31, 2025Research & Development
48.41MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
268.86MCNYFY2025 · Dec 31, 2025Other Operating Expenses
-6.50MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
43.41MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
720.00KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0625CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0625CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.51BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.51BSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
-40.88MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
135.45MCNYFY2025 · Dec 31, 2025Free Cash Flow
48.02MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.80BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
164.99MCNYFY2025 · Dec 31, 2025Stock-based Compensation
26.45MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-41.96MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
3.47MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-17.50MCNYFY2025 · Dec 31, 2025Capital Expenditures
-87.43MCNYFY2025 · Dec 31, 2025Net Intangibles (CF)
-15.01MCNYFY2025 · Dec 31, 2025Purchase of Investments
-270.50MCNYFY2025 · Dec 31, 2025Sale of Investments
274.86MCNYFY2025 · Dec 31, 2025Other Investing Activity
283.00KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-82.78MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
9.20MCNYFY2025 · Dec 31, 2025Common Stock Repurchase
-19.76MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-130.35MCNYFY2025 · Dec 31, 2025Other Financing Charges
17.25MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-123.66MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.47BSharesUpdated Sep 20, 2026Float Shares
366.79MSharesUpdated Sep 20, 2026% Held by Insiders
74.37%vs all stocks
% Held by Institutions
0.53%vs all stocks
Total Cash (MRQ)
2.14BCNY272.52M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.28CNYUpdated Sep 20, 2026Total Debt (MRQ)
24.60MCNY3.14M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0044xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
9.38xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
3.17CNYUpdated Sep 20, 2026Total Assets
5.24BCNY781.20M · vs all stocks (USD)
Total Current Assets
2.36BCNYFY2025 · Dec 31, 2025Total Liabilities
381.52MCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.87BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
164.72MCNYFY2025 · Dec 31, 2025Total Current Liabilities
216.80MCNYFY2025 · Dec 31, 2025Cash
1.16BCNYFY2025 · Dec 31, 2025Cash Equivalents
638.11MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.80BCNYFY2025 · Dec 31, 2025Other Short-term Investments
5.00MCNYFY2025 · Dec 31, 2025Accounts Receivable
67.39MCNYFY2025 · Dec 31, 2025Inventory
145.20MCNYFY2025 · Dec 31, 2025Accounts Payable
58.79MCNYFY2025 · Dec 31, 2025Short-term Debt
17.25MCNYFY2025 · Dec 31, 2025Long-term Debt
4.75MCNYFY2025 · Dec 31, 2025Common Stock (Book)
897.00KCNYFY2025 · Dec 31, 2025Retained Earnings
2.14BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.85BCNY724.27M · vs all stocks (USD)
Treasury Stock
2.75MCNYFY2025 · Dec 31, 202552-Week Low
0.8750HKDUpdated Sep 20, 202652-Week High
1.63HKDUpdated Sep 20, 202652-Week Change
-42.40%vs all stocks
Beta
0.7000xvs all stocks
50-Day MA
0.9767HKDUpdated Sep 20, 2026200-Day MA
1.15HKDUpdated Sep 20, 2026Avg 10-Day Volume
411.70KSharesUpdated Sep 20, 2026Avg 30-Day Volume
551.53KSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.0700CNYUpdated Sep 20, 20265 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Retained Earnings Heavy With Elevated Payout
Profits kept in the business fund much of what it owns, and it now pays out most of what it earns.
Reads
How does this company use capital?
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 12.86×, lower than 95% of its Medical Instruments & Supplies peers (median 26.23×)Notable
P/E ratio: 12.86Industry median: 26.23Industry P5: 12.86Peers compared: 62.00
Price-to-book is 0.28×, lower than 95% of its Medical Instruments & Supplies peers (median 2.75×)Notable
Price-to-book: 0.28Industry median: 2.75Industry P5: 0.85Peers compared: 62.00
Financial Health
Altman Z-Score 3.96: safe zoneNotable
Altman Z-Score: 3.96
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $249.86M, lower than 95% of all stocks globallySignificant
Market cap (USD): 249,862,471.046Global P5: 275,556,405.438
Companies that share the same coordination system — how they create, deliver, or capture value.
Gltechno Holdings Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Jilin Asia Link Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Saha-Union Corporation Public Company Limited
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Shanghai Baolijia Chemical Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Eveready Industries India Ltd.
Tier 1ProductionThroughput-Bound ConversionFlow
Hansol IONES Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hansae Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowInterface
Federal Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Salmon Evolution ASA
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Darwin Precisions Corporation
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Games Workshop Group PLC
6 interpretationsHigh Dividend Payout With FCF And Equity RatioHigh Retained Earnings With Profitability And EquityCash Backing With Revenue And Income StreaksLiquidity Ratios ElevatedRetained Earnings Heavy With Elevated PayoutLow-Leverage Liquidity Configuration
China World Trade Center Co., Ltd.
5 interpretationsHigh Dividend Payout With FCF And Equity RatioHigh Retained Earnings With Profitability And EquityLiquidity Ratios ElevatedRetained Earnings Heavy With Elevated PayoutLow-Leverage Liquidity Configuration
Ningbo United Group Co., Ltd.
5 interpretationsHigh Dividend Payout With FCF And Equity RatioHigh Retained Earnings With Profitability And EquityLiquidity Ratios ElevatedRetained Earnings Heavy With Elevated PayoutLow-Leverage Liquidity Configuration